Hints and tips:
Related Special Reports
...At the mid-level, a cashmere style in a muted shade from Sheep Inc, John Smedley or — my favourite — Begg x Co will quickly become a staple of your wardrobe....
...Shah Capital does not have an issue with the leadership of Novavax chief executive John Jacobs and was pleased with his negotiation of a $349.6mn settlement with the Canadian government over the forfeiting...
...John Jacobs told the Financial Times there was no guarantee governments would deliver on all their existing commitments with the company, which include $2.1bn in advanced purchase agreements signed with...
...(Pimco) — The PagerDuty CEO who quoted Martin Luther King in her mass sacking email is v v v sorry....
...john.gapper@ft.com...
...Job moves JPMorgan Chase has hired John China — the president of Silicon Valley Bank’s venture capital arm SVB Capital — as co-head of innovation economy based in San Francisco....
...Novavax’s Stanley Erck will be replaced by John C Jacobs, most recently chief executive at Harmony Biosciences, this month; CureVac’s Franz-Werner Haas will be succeeded by Alexander Zehnder, a Sanofi veteran...
...David Dowdy, an epidemiologist at Johns Hopkins School of Medicine, said the delay made sense given that case rates in the US are declining rapidly and that new data on a three-dose regimen should be available...
...Amesh Adalja, an infectious disease specialist at Johns Hopkins Center for Health Security, said it would have been better to have an Omicron-based version of the vaccine before the variant surged....
...ExxonMobil’s stock market recovery first began when Pfizer et al announced that they had developed a strong slate of anti-Covid vaccines in November 2020....
...Two doses of the BioNTech/Pfizer vaccine provide 70 per cent protection against being admitted to hospital with the Omicron coronavirus variant, according to the first real-world analysis of protection against...
...“Thanks to their hard work, we achieved a vaccine in record time and currently have multiple vaccines available — enough to reach every corner of the globe,” said John Murphy, chief policy officer at Bio...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Additional reporting by John Burn-Murdoch in London...
...However, it remains to be seen how long a booster can protect for, when “antibody levels wax and wane”, said Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security....
...vaccinated and there is not enough vaccine uptake in the population above 12 years [of age] to prevent cases recognised in schools from disrupting in-person learning,” said Amesh Adalja, a senior scholar at the Johns...
...However, Ugur Sahin, head of BioNTech, who developed the vaccine now produced by Pfizer, struck a more positive note....
...John Trizzino, chief commercial officer at Novavax, reminded a conference recently. “It’s a good vaccine,” he generously said of Pfizer and Moderna’s efforts, “but there’s a need for our vaccine.”...
...David Dowdy, an epidemiologist at Johns Hopkins School of Medicine, said the number one message is that existing data showed that all of the widely used vaccines are exceptionally safe....
...John Moore, a virologist at Cornell University, said the key question was whether the populations receiving each vaccine were comparable because local factors such as who is prioritised for each vaccine...
...New York Fed president John Williams will participate in a discussion hosted by The New York Times on “Health and the Economy.”...
...The makers of Russia’s Sputnik V have said it was “more efficient against the Delta variant of coronavirus . . . than any other vaccine that published results on this strain so far”, but provided no evidence...
...The relative drop in efficacy against B.1.617.2 was similar for both vaccines: amounting to 6 per cent for the BioNTech/Pfizer vaccine, and 10 per cent for Oxford/AstraZeneca....
...This came after Prayuth Chan-ocha, the prime minister, said on Thursday that Russian President Vladimir Putin had promised to provide Thailand with an undisclosed amount of Sputnik V vaccines under a government...
...In the autumn of 2020, according to data from Johns Hopkins University, the Jewish state had the highest rate of new infections per capita of any country in the world....
International Edition